J JUVENESCENCE
Live / Applied — Fourth extension granted (statement of use) (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 21 Jul 2020 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90065002
- Mark type
- Design + words
- Filed
- 21 Jul 2020
- Published for opposition
- 20 Feb 2024
- Attorney of record
- Joshua S. Wolkoff
Goods and services
- Class 005 — Pharmaceuticals: Nutritional supplements; medicinal food supplements; nutraceuticals for use as a dietary supplement; medicines, namely, medicinal preparations for prevention and treatment of physiological aging, cognitive aging and senescence; and pharmaceuticals, namely, pharmaceutical preparations for prevention and treatment of physiological aging, cognitive aging and senescence
- Class 009 — Scientific and electric apparatus: Downloadable software, namely mobile and computer applications, for recording user health data, for tracking user activity and nutrition and other lifestyle-related behaviors, and for providing personalized antiaging, health, and wellbeing information and recommendations; non-medical wearable digital electronic devices comprised primarily of software for recording user health data, for tracking user activity and nutrition and other lifestyle-related behaviors, and for providing personalized antiaging, health, and wellbeing information and recommendations
- Class 010 — Medical apparatus: Surgical apparatus and instruments; medical apparatus and instruments, namely biosensors for detecting biomarkers; medical devices, namely, patient monitors and patient sensors being wearable medical devices for recording user health data, for tracking user activity and nutrition and other lifestyle-related behaviors, and for providing personalized antiaging, health, and wellbeing information and recommendations
- Class 035 — Advertising and business services: Business consulting and management of research and development, of clinical research and trials, and of regulatory approval, and marketing the goods of others in the field of medical, biopharmaceutical, and biotechnology products and software technologies
- Class 036 — Insurance and financial services: Providing venture capital, development capital, private equity and investment funding in the field of biotechnology, pharmaceuticals, and medical devices and technologies
- Class 042 — Scientific and technological services: Research and development of pharmaceutical preparations and medicines; medical and scientific research in the field of human health and aging; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the fields of protocols and techniques for life extension and for prevention of aging, of anti-aging pharmaceuticals, and of anti-aging devices; computer software development in the field of applications for anti-aging and life extension; providing online non-downloadable computer programs for cognitive stimulation, and for training and education related thereto; research in the field of artificial intelligence; providing temporary use of non-downloadable software for recording user health data, for tracking user activity and nutrition and other lifestyle-related behaviors, and for providing personalized antiaging, health, and wellbeing information and recommendations; Platform as a Service (PaaS) featuring computer software platforms for recording user health data, for tracking user activity and nutrition and other lifestyle-related behaviors, and for providing personalized antiaging, health, and wellbeing information and recommendations
- Class 044 — Medical, beauty and agricultural services: Medical services; providing information in the field of health via a website
Owner
- Juvenescence (Europe) Limited, DUBLIN 2, IE
- Juvenescence (Europe) Limited, Dublin, IE
Prosecution history
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2026 — SOU EXTENSION 4 GRANTED
- 12 Mar 2026 — SOU EXTENSION 4 FILED
- 12 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2025 — SOU EXTENSION 3 GRANTED
- 05 Sept 2025 — SOU EXTENSION 3 FILED
- 05 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2025 — SOU EXTENSION 2 GRANTED
- 26 Mar 2025 — SOU EXTENSION 2 FILED
- 26 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Sept 2024 — SOU EXTENSION 1 GRANTED
- 20 Sept 2024 — SOU EXTENSION 1 FILED